154 related articles for article (PubMed ID: 37106339)
1. Overexpression of DDX49 in prostate cancer is associated with poor prognosis.
Tao J; Ge Q; Meng J; Liang C; Hao Z; Zhou J
BMC Urol; 2023 Apr; 23(1):66. PubMed ID: 37106339
[TBL] [Abstract][Full Text] [Related]
2. DDX49 Promotes Proliferation and Metastasis of Cervical Cancer by Regulation of AKT and Wnt/β-Catenin Signalings.
Chen Y; Ma Q; Sun N
Ann Clin Lab Sci; 2023 Mar; 53(2):271-277. PubMed ID: 37094865
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
4. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
5. DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Lian X; Xiang D; Peng C; Chen J; Liao M; Sun G; Zhang Z
J Cell Mol Med; 2020 Jan; 24(1):1141-1145. PubMed ID: 31749282
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG20 promoted proliferation, invasion and inhibited cell apoptosis of lung adenocarcinoma via sponging miR-342 and upregulating DDX49.
Wang X; Gu G; Zhu H; Lu S; Abuduwaili K; Liu C
Thorac Cancer; 2020 Dec; 11(12):3510-3520. PubMed ID: 33089952
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the nucleosome-binding protein 1 (NSBP1) gene can inhibit the in vitro and in vivo proliferation of prostate cancer cells.
Jiang N; Zhou LQ; Zhang XY
Asian J Androl; 2010 Sep; 12(5):709-17. PubMed ID: 20531280
[TBL] [Abstract][Full Text] [Related]
8. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
[TBL] [Abstract][Full Text] [Related]
9. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
Song Y; Song C; Yang S
Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
11. MTSS1 hypermethylation is associated with prostate cancer progression.
Chen J; Huang L; Zhu Q; Wang Z; Tang Z
J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer.
Zeng T; Zhu L; Liao M; Zhuo W; Yang S; Wu W; Wang D
Med Oncol; 2017 Feb; 34(2):27. PubMed ID: 28078560
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
Tian F; Cai D
Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
[TBL] [Abstract][Full Text] [Related]
15. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
[TBL] [Abstract][Full Text] [Related]
16. COPB2 Is Upregulated in Prostate Cancer and Regulates PC-3 Cell Proliferation, Cell Cycle, and Apoptosis.
Mi Y; Yu M; Zhang L; Sun C; Wei B; Ding W; Zhu Y; Tang J; Xia G; Zhu L
Arch Med Res; 2016 Aug; 47(6):411-418. PubMed ID: 27986120
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
Chen C; Cai Z; Zhuo Y; Xi M; Lin Z; Jiang F; Liu Z; Wan Y; Zheng Y; Li J; Zhou X; Zhu J; Zhong W
BMC Cancer; 2020 Apr; 20(1):289. PubMed ID: 32252682
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer.
Nip H; Dar AA; Saini S; Colden M; Varahram S; Chowdhary H; Yamamura S; Mitsui Y; Tanaka Y; Kato T; Hashimoto Y; Shiina M; Kulkarni P; Dasgupta P; Imai-Sumida M; Tabatabai ZL; Greene K; Deng G; Dahiya R; Majid S
Oncotarget; 2016 Oct; 7(42):68371-68384. PubMed ID: 27634912
[TBL] [Abstract][Full Text] [Related]
19. KDM6B is an androgen regulated gene and plays oncogenic roles by demethylating H3K27me3 at cyclin D1 promoter in prostate cancer.
Cao Z; Shi X; Tian F; Fang Y; Wu JB; Mrdenovic S; Nian X; Ji J; Xu H; Kong C; Xu Y; Chen X; Huang Y; Wei X; Yu Y; Yang B; Chung LWK; Wang F
Cell Death Dis; 2021 Jan; 12(1):2. PubMed ID: 33414463
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
